| Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2010: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2009: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2008: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
|---|
| Research Abstract |
For the RBD patients, the related factors developing RBD to α-synucleinopathy were examined, prospectively. In the study period, follow-up period is one to two years, currently, and has to be short. In subjects, progression to α-synucleinopathy was not observed in this period. It is important to evaluate the long-term course for idiopathic RBD. From previous studies to date, it is considered that we should continue evaluation of factors indicating the development of α-synucleinopathy in the future study.
|
